Johannesburg – Pharmaceutical giant Aspen says there will be enough supplies of the Dexamethasone drug which is used to treat severely ill Covid-19 patients.
An Oxford University’s recovery trial recently found that the anti-inflammatory medicine causes a 35 % reduction in the deaths of critically ill patients.
Health Minister Zweli Mkhize says there are currently around 300 000 units of the product available in the country, and South African doctors are able to offer the treatment to those who need it.
Aspen Pharmacare Group’s executive Stavros Nicolaous says the drug has a much targeted therapeutic range.
“It does have generic forms, so there are other suppliers in the country. We are confident that with Aspen and other suppliers, we are able to keep a stable and constant supply in the country,” Nicolaous adds.